Target intelligence / Profile preview

Protein-bound uremic toxin (PBUT)

Target
PBUT
Molecular classification
Other
01

Overview

Protein-bound uremic toxins (PBUTs) are a broad class of small, low molecular weight toxic molecules that accumulate in the bloodstream of patients with impaired kidney function, especially chronic kidney disease. These toxins are generated mainly by gut microbial metabolism of dietary proteins and are characterized by a strong binding affinity to plasma proteins, primarily albumin, which makes them difficult to eliminate by standard dialysis methods. PBUT accumulation is implicated in the development of uremic syndrome, cardiovascular disease, inflammation, and immune dysfunction. Key representatives of this group include indoxyl sulfate, p-cresyl sulfate, hippuric acid, among others. Due to their problematic removal and central role in disease pathology, PBUTs are the focus of ongoing research and therapeutic innovation, particularly around displacing them from albumin to enhance their clearance[1][3][4][6][7].

Other names
Protein-bound uremic toxinsPBUTsprotein-bound solutes
02

Mechanism of action

Competitive displacement from albumin binding sites to increase the free fraction and facilitate removal by dialysis or filtration

03

Biological functions

Other
04

Disease associations

Cardiovascular diseaseInflammationOther
05

Safety considerations

Difficulty in removal by conventional dialysis (due to high albumin-binding affinity, most PBUTs are not efficiently removed by standard dialysis, presenting a major clinical challenge)Risk of toxicity if displaced acutely without effective clearance, potentially leading to higher free toxin concentrations in plasma
06

Interacting drugs

Ibuprofen

5 more in the full profile.

07

Biomarkers

Plasma levels of protein-bound uremic toxins (such as indoxyl sulfate, p-cresyl sulfate)

Beyond the preview

Go deeper on Protein-bound uremic toxin (PBUT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein-bound uremic toxin (PBUT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call